An LHRH peptide-conjugated ruthenium(II) complex as tumor-targeted theranostic anticancer agent

Yafang Qin,Xingguo Tang, Jintai Chen, Jingcong Huang,Dingding Wang,Xianhuan Zhang, Yangli Zhang,Fenglin Wu,Jinquan Wang

Inorganic Chemistry Communications(2022)

Cited 2|Views4
No score
Abstract
An LHRH-peptide conjugated ruthenium(II) complex exhibited excellent photophysical properties and antitumor effects, which has been explored as a tumor-targeted theranostic anticancer agent.
More
Translated text
Key words
Ruthenium(II) complex,LHRH peptide,Tumor-targeted,Theranostic
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined